TCR2 Therapeutics Inc. Stock
Equities
TCRR
US87808K1060
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Garry Menzel
CEO | Chief Executive Officer | 59 | 15-12-31 |
William Bertrand
PSD | President | 59 | 23-05-31 |
Robert Tighe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Garry Menzel
CEO | Chief Executive Officer | 59 | 15-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
1st Jan change | Capi. | |
---|---|---|
-1.78% | 41.36B | |
+47.70% | 41.3B | |
+4.01% | 39.61B | |
-15.14% | 25.62B | |
+3.16% | 24.09B | |
-24.08% | 18.38B | |
-2.67% | 11.82B | |
+24.76% | 11.85B | |
+7.01% | 11.07B |